Biomedicine and Money
Do you think you would be willing to receive medical treatment that is very effective but expensive? Many of you
Many of you would probably give up due to the cost. In order for biomedicine to reach everyone, we have to consider the issue of money.
Biopharmaceuticals are more effective and have fewer side effects than conventional drugs, making them an area of biomedicine that is attracting a lot of attention.
However, biopharmaceuticals are "very expensive". The reason for this is the manufacturing process and the price of materials.
Biopharmaceuticals are highly effective but very expensive. How can we solve this problem?
Biosimilars" make biotech drugs a little cheaper.
One way to use biopharmaceuticals at a lower cost is to use generic versions of them.
The term "biosimilar" means "similar" in English. The term "biosimilar" means "similar" in English.
This means that after the patent of a biopharmaceutical (prior biopharmaceutical) expires, a company other than the company that developed the drug manufactures and sells it with the same quality, safety and efficacy.
Since biopharmaceuticals are susceptible to differences in manufacturing processes, biosimilars must undergo a rigorous review process when they are manufactured.
With the spread of biosimilars, it is expected that more people will be afford biopharmaceuticals.
Challenges of Biosimilars
Biosimilars are no different in that they are cheaper than biopharmaceuticals, but unlike generics of conventional drugs, biopharmaceuticals are difficult to manufacture.
Conventional chemically produced drugs are easy to synthesize, and it is only a matter of obtaining the "recipe" for the drug, but even if the "recipe" for biopharmaceuticals is obtained
However, even if the "recipe" for a biopharmaceutical is available, the "technology" to produce it is required at the same time, and the cost of production is quite high. The current situation is that biosimilars are not very cheap.
